Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of the effectiveness of Curosurf with Beraksurf in the treatment of respiratory distress in premature infants
IRCT20190418043307N2Phase 2Completed
- Sponsor
- Ilam University of Medical Sciences
- Start
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of Poractant alfa and beractant in respiratory distress syndrome (RDS) (2 arms), sponsored by Ilam University of Medical Sciences. Started Jun 2020; status: completed.
02
Drugs
Poractant alfaberactant
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT20190418043307N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190418043307N2.